Your browser is no longer supported. Please, upgrade your browser.
Settings
INSY INSYS Therapeutics, Inc. daily Stock Chart
INSY [NASD]
INSYS Therapeutics, Inc.
Index- P/E24.94 EPS (ttm)0.67 Insider Own0.80% Shs Outstand72.03M Perf Week0.60%
Market Cap1.20B Forward P/E14.26 EPS next Y1.17 Insider Trans-4.00% Shs Float24.48M Perf Month-33.98%
Income50.80M PEG0.89 EPS next Q0.30 Inst Own51.90% Short Float85.55% Perf Quarter-39.61%
Sales306.20M P/S3.93 EPS this Y-25.70% Inst Trans1.66% Short Ratio22.16 Perf Half Y-54.56%
Book/sh3.29 P/B5.08 EPS next Y-12.01% ROA19.30% Target Price46.00 Perf Year-34.82%
Cash/sh2.16 P/C7.74 EPS next 5Y28.00% ROE25.60% 52W Range14.18 - 46.17 Perf YTD-41.63%
Dividend- P/FCF16.42 EPS past 5Y17.30% ROI22.80% 52W High-63.81% Beta2.28
Dividend %- Quick Ratio2.80 Sales past 5Y- Gross Margin90.80% 52W Low17.84% ATR1.93
Employees382 Current Ratio3.40 Sales Q/Q56.60% Oper. Margin25.80% RSI (14)32.97 Volatility9.62% 11.65%
OptionableYes Debt/Eq0.00 EPS Q/Q112.50% Profit Margin16.60% Rel Volume0.78 Prev Close16.70
ShortableYes LT Debt/Eq0.00 EarningsFeb 23 BMO Payout0.00% Avg Volume944.88K Price16.71
Recom2.00 SMA20-12.82% SMA50-32.39% SMA200-45.49% Volume733,717 Change0.06%
Feb-01-16Reiterated RBC Capital Mkts Outperform $49 → $44
Mar-09-15Reiterated RBC Capital Mkts Outperform $65 → $71
Mar-04-15Reiterated RBC Capital Mkts Outperform $57 → $65
Dec-15-14Reiterated RBC Capital Mkts Outperform $53 → $57
Nov-12-14Reiterated RBC Capital Mkts Outperform $51 → $53
Nov-12-14Downgrade Oppenheimer Outperform → Perform $40
Oct-02-14Initiated RBC Capital Mkts Outperform $51
Aug-14-13Reiterated Oppenheimer Outperform $23 → $27
Jul-31-13Initiated Oppenheimer Outperform $23
Feb-10-16 04:40PM  INSYS (INSY) Initiates Phase II Study for Infantile Spasms +6.30%
10:05AM  Deadline in Lawsuit for Investors in Insys Therapeutics Inc (NASDAQ:INSY) Announced by Shareholders Foundation GlobeNewswire
06:50AM  Insys Therapeutics, Inc. to Present at RBC Capital Markets 2016 Global Healthcare Conference GlobeNewswire
Feb-09-16 02:31PM  INVESTOR ALERT: Lundin Law PC Announces an Ongoing Investigation of INSYS Therapeutics, Inc. and Urges Investors with Losses to Contact the Firm Business Wire +5.86%
12:47PM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against INSYS Therapeutics, Inc. Business Wire
12:08PM  SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notify Investors of Class Action Involving INSYS Therapeutics, Inc. and a Lead Plaintiff Deadline of April 4, 2016 - INSY GlobeNewswire
10:30AM  Glancy Prongay & Murray Investigates Claims on Behalf of Insys Therapeutics, Inc. Investors Business Wire
08:30AM  Hagens Berman Advises Insys Therapeutics Inc. (NASDAQ:INSY) Investors of April 4, 2016, Lead Plaintiff Deadline in a Newly Filed Class Action GlobeNewswire
06:50AM  Insys Therapeutics Enrolls First Patient in Phase II Study for the Treatment of Infantile Spasms Using Pharmaceutical CBD GlobeNewswire
Feb-08-16 08:00PM  Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Insys Therapeutics, Inc. to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit INSY GlobeNewswire -9.18%
06:04PM  INVESTOR NOTICE: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit Against INSYS Therapeutics, Inc. and Encourages Investors With Losses in Excess of $100,000 to Contact the Firm Business Wire
03:31PM  SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Insys Therapeutics, Inc. to Contact the Firm Before Lead Plaintiff Deadline Marketwired
12:35PM  IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit Against INSYS Therapeutics, Inc. and Encourages Investors with Losses In Excess of $100,000 to Contact the Firm Business Wire
09:11AM  Law Offices of Marc S. Henzel Announces Investigation of Companies for Violations of the Federal Securities Laws PR Newswire
Feb-06-16 12:01AM  Kessler Topaz Meltzer & Check, LLP Files Shareholder Class Action Against Insys Therapeutics, Inc. - INSY Accesswire
Feb-05-16 10:00PM  The Former Attorney General of Louisiana & Kahn Swick & Foti, LLC Remind Large Investors of Lead Plaintiff Deadline in Class Action Lawsuit Against Insys Therapeutics, Inc. - INSY GlobeNewswire
07:07PM  INVESTOR NOTICE: Goldberg Law PC Files Securities Class Action Lawsuit against INSYS Therapeutics, Inc. and Strongly Encourages Investors to Contact the Firm Business Wire
05:30PM  Bragar Eagel & Squire, P.C. Is Investigating the Officers and Directors of Insys Therapeutics Incorporated (INSY) on Behalf of Stockholders and Encourages Investors to Contact the Firm Business Wire
03:14PM  INVESTOR ALERT: Investigation of Insys Therapeutics, Inc. Announced by Law Offices of Howard G. Smith Business Wire
02:14PM  SHAREHOLDER NOTICE: Khang & Khang LLP Announces an Investigation of Claims against INSYS Therapeutics, Inc. and Strongly Encourages Investors to Contact the Firm Business Wire
11:51AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of INSYS Therapeutics, Inc. of Class Action Lawsuit and a Lead Plaintiff Deadline of April 4, 2016 INSY GlobeNewswire
Feb-04-16 05:00PM  Bernstein Liebhard LLP Announces That A Suit Has Been Filed Against Insys Therapeutics Inc. PR Newswire +6.34%
11:45AM  IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces an Investigation of Claims against INSYS Therapeutics, Inc. and Strongly Encourages Investors to Contact the Firm Business Wire
11:05AM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Shareholders of Insys Therapeutics, Inc. - INSY Accesswire
10:00AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against INSYS Therapeutics, Inc. (INSYS) and Lead Plaintiff Deadline: April 4, 2016 PR Newswire
Feb-03-16 09:37PM  IMPORTANT SHAREHOLDER ALERT: Goldberg Law PC Files Securities Class Action Lawsuit Against INSYS Therapeutics, Inc. and Strongly Encourages Investors to Contact the Firm Business Wire
04:30PM  Insys Therapeutics to Report Fourth Quarter and Full Year 2015 Results GlobeNewswire
03:04PM  Harwood Feffer LLP Announces Investigation of Insys Therapeutics, Inc. PR Newswire
10:05AM  /C O R R E C T I O N -- Kessler Topaz Meltzer & Check, LLP/ PR Newswire
09:30AM  The Zacks Analyst Blog Highlights: Gilead Sciences, Mylan, United Therapeutics and INSYS Therapeutics
Feb-02-16 10:46AM  4 Top-Ranked Biotech Stocks on Sale -5.83%
08:40AM  Why Insys Therapeutics Shares Got Trounced in January at Motley Fool
Jan-28-16 02:05PM  7 Stocks With Short Interests of 40% to 80% of Their Float at 24/7 Wall St. -9.06%
Jan-25-16 09:41PM  IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Claims against INSYS Therapeutics, Inc. and Strongly Encourages Investors to Contact the Firm Business Wire
12:55PM  Insys Therapeutics Releases Statement on Its Patient Services Center GlobeNewswire
11:28AM  Insys Therapeutics Investigated for Securities Fraud By Block & Leviton LLP After Publication Of Reports Accusing The Company Of Insurance Fraud PR Newswire
10:35AM  Insys Therapeutics: The Brotherhood of Thieves?
Jan-17-16 07:01AM  11 Facts You Didn't Know About Marijuana at Motley Fool
Jan-09-16 12:01PM  Why This Marijuana Stock Crashed 18% in December at Motley Fool
Jan-08-16 07:20AM  4 Pharmaceutical Stocks With Big Catalysts Pending in 2016 at 24/7 Wall St. -6.57%
Jan-06-16 04:00PM  Waters Secures Regulatory Approvals for LC-MS Products
Jan-05-16 08:27AM  INSYS Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : January 5, 2016
Dec-31-15 10:10AM  Hill-Rom's Welch Allyn Buy to Boost Growth, Margins Weak
Dec-30-15 07:00AM  Insys Therapeutics, Inc. to Present at J.P. Morgan 34th Annual Healthcare Conference GlobeNewswire
Dec-28-15 12:30PM  Boston Scientific: Emerging Markets Impress, Currency Bothers
Dec-22-15 02:50PM  BioScrip: Infusion Services Offers Hope amid Margin Woes
12:00PM  Rising Demand for Pain Medicine Could Boost These Stocks In 2016 at Motley Fool
Dec-21-15 02:30PM  Zimmer Biomet: Portfolio Expansion Strong, Revenues Stumble
02:25PM  FDA Okays Bio-Rad D-100 for HbA1c (Diabetes) Testing
02:20PM  Phibro Animal Health Shines in Emerging Markets, Q1 Strong
Dec-14-15 01:08PM  Commodities Fell, XBI Was the Weaker Biotech ETF
Dec-11-15 07:59AM  3 Stocks the Market Hates But Analysts Love at TheStreet
Dec-09-15 08:43AM  Investors' Radars Failed to Catch INSYS Therapeutics (INSY), Has Yours?
Dec-08-15 01:17PM  INSYS THERAPEUTICS, INC. Financials +6.64%
08:25AM  Blue Chip Biotech Highlights Jefferies 4 Top Growth Stocks to Buy Now at 24/7 Wall St.
Dec-06-15 07:00AM  Why Medical Marijuana Caused GW Pharmaceuticals to Climb 10% in November at Motley Fool
Dec-05-15 10:28AM  Is Insys Therapeutics Inc (INSY) A Good Stock To Buy? at Insider Monkey
Dec-04-15 12:43PM  INSYS Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : December 4, 2015
11:28AM  The SPDR S&P Biotech ETF Lingers in the Red as of December 3
08:22AM  What's Going On With Insys Therapeutics?
07:00AM  Insys Therapeutics Responds to False and Misleading Report GlobeNewswire
Dec-03-15 04:20PM  Why Insys Therapeutics Shares Sky-Rocketed Last Month at Motley Fool -18.54%
01:33PM  The group that helped break open the Valeant story just called another pharma company 'Murder Incorporated'
Dec-02-15 11:25AM  INSYS Therapeutics, Inc. Earnings Q3, 2015
07:30AM  Insys Therapeutics, Inc. Announces Speakers for December 3, 2015 Investor Day GlobeNewswire
Dec-01-15 03:48PM  Waters Corp. Opens Office at Malaysia to Spur Growth
Nov-29-15 07:18AM  Hedge Funds Are Crazy About Electronics For Imaging, Inc. (EFII) at Insider Monkey
Nov-25-15 02:00PM  Insys Led IBBs Mid-Cap Stocks
Nov-24-15 07:00AM  Insys Therapeutics, Inc. to Host Investor Day on December 3, 2015 GlobeNewswire
Nov-23-15 04:30PM  Insys Therapeutics, Inc. to Present at Piper Jaffray 27th Annual Healthcare Conference GlobeNewswire +8.11%
12:47PM  Insys Therapeutics, Inc. Issues Statement GlobeNewswire
Nov-19-15 09:39AM  Can the Rally in INSYS (INSY) Shares Continue?
Nov-17-15 06:30PM  3 Stocks the Market Loves to Hate at Motley Fool
Nov-12-15 08:00AM  Insys Therapeutics, Inc. to Present at Jefferies Autumn 2015 Global Healthcare Conference GlobeNewswire +7.21%
Nov-11-15 06:27PM  Why Insys Therapeutics Shares Dropped Today at Motley Fool -8.71%
10:08AM  Celldex Leads the Small-Cap Stocks in IBB
Nov-10-15 12:56PM  Here's Why Galena Biopharma's Stock Tanked Today at Motley Fool
Nov-08-15 10:20AM  Will Allegations Derail Insys' Rapid Sales Growth? at Motley Fool
Nov-06-15 02:21PM  Edited Transcript of INSY earnings conference call or presentation 5-Nov-15 3:00pm GMT +7.71%
Nov-05-15 11:24AM  Insys investigation in at least 6 states
09:48AM  Insys CEO Babich resigns, drugmaker tops 3Q expectations
08:29AM  CEO of controversial drug company Insys is out at CNBC
07:59AM  INSYS THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial S
07:07AM  Q3 2015 INSYS Therapeutics Inc Earnings Release - Before Market Open
06:52AM  Insys Therapeutics Announces Stock Repurchase Program GlobeNewswire
06:51AM  Insys Therapeutics Announces Senior Management Changes and Appointments GlobeNewswire
06:50AM  Insys Therapeutics Reports Record Third Quarter 2015 Results GlobeNewswire
Nov-04-15 10:13AM  A drug stock skyrocketing from painkiller profits at CNBC -8.50%
Oct-30-15 08:19AM  Why biotech could be on the verge of a rebound
Oct-29-15 03:03PM  Insys Therapeutics Announces Its Naloxone Sublingual Spray Received Fast Track Designation From the FDA for the Treatment of Opioid Intoxication or Overdose Marketwired
09:35AM  6 Top Specialty Pharmaceutical Stocks to Buy With Over 100% Upside Potential at 24/7 Wall St.
Oct-26-15 02:56PM  Insys Therapeutics Issues Statement on Its Use of Specialty Pharmacies Marketwired
Oct-23-15 11:08AM  IBBs Top 10 Small-Cap Stocks Underperformed on October 21
Oct-22-15 07:00AM  Insys Therapeutics to Report Third Quarter 2015 Results Marketwired -7.19%
Oct-17-15 01:41PM  3 Biotechs Stocks That We Think The Market Has All Wrong at Motley Fool
Oct-16-15 11:06AM  Radius Continued to Fall despite Positive Data on Osteoporosis
Sep-28-15 06:06PM  3 Biotech Stocks Short-Sellers Have Targeted the Most at Motley Fool
Sep-25-15 08:34AM  3 Mid-Cap Biotechs We're Excited About at Motley Fool -8.75%
Sep-24-15 07:00AM  Insys Therapeutics In-Licenses Cannabinoid Inhalation Technology Marketwired
Sep-23-15 04:01PM  These Healthcare Stocks Could Be Primed for a Short Squeeze at Motley Fool
Insys Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes supportive care products. The company markets Subsys, a proprietary sublingual fentanyl spray for breakthrough cancer pain in opioid-tolerant cancer patients; and Dronabinol SG Capsule, a dronabinol soft gelatin capsule that is generic equivalent to Marinol, an approved second-line treatment for chemotherapy-induced nausea and vomiting, and anorexia associated with weight loss in patients with AIDS. Its products candidates also include Dronabinol Oral Solution, a proprietary orally administered liquid formulation of dronabinol. The company is headquartered in Chandler, Arizona.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MEYER STEVEN JDirectorFeb 05Option Exercise8.3218,000149,83018,000Feb 09 02:12 PM
FOURTEAU PATRICKDirectorNov 12Sale26.4830,000794,40079,682Nov 13 03:38 PM
JOHN N KAPOOR TRUST DATED SEPT10% OwnerNov 11Buy25.5210,000255,22142,359,610Nov 13 03:25 PM
Babich Michael LPresident and CEOSep 22Option Exercise1.6216,06826,030421,572Sep 22 06:36 PM
STANLEY THEODORE HDirectorSep 14Option Exercise3.632,0007,2604,000Sep 14 05:24 PM
STANLEY THEODORE HDirectorSep 14Sale38.082,00076,1602,000Sep 14 05:24 PM
STANLEY THEODORE HDirectorSep 10Option Exercise3.632,0007,2604,000Sep 14 05:24 PM
STANLEY THEODORE HDirectorSep 10Sale36.002,00072,0072,000Sep 14 05:24 PM
Del Fosse FrancGeneral CounselJun 10Option Exercise13.2710,000132,70010,000Jun 10 05:56 PM
Del Fosse FrancGeneral CounselJun 10Sale34.4810,000344,8000Jun 10 05:56 PM
MEYER STEVEN JDirectorJun 05Sale63.005,000315,0000Jun 05 05:55 PM
Tambi BrianDirectorMay 27Option Exercise1.223,1003,7823,100May 27 06:14 PM
Tambi BrianDirectorMay 27Sale60.093,100186,2790May 27 06:14 PM
FOURTEAU PATRICKDirectorMay 27Sale60.141,31178,84454,841May 27 06:13 PM
Tambi BrianDirectorMay 26Option Exercise1.221,8002,1961,800May 27 06:14 PM
Tambi BrianDirectorMay 26Sale60.001,800108,0000May 27 06:14 PM
FOURTEAU PATRICKDirectorMay 26Sale60.004,784287,04056,152May 27 06:13 PM
Tambi BrianDirectorMay 20Option Exercise1.223,9004,7583,900May 20 05:28 PM
FOURTEAU PATRICKDirectorMay 20Sale60.006,095365,70060,936May 20 05:55 PM
Tambi BrianDirectorMay 20Sale60.143,900234,5460May 20 05:28 PM
Tambi BrianDirectorMay 19Option Exercise1.221,2001,4641,200May 20 05:28 PM
FOURTEAU PATRICKDirectorMay 19Sale60.002,969178,14067,031May 20 05:55 PM
Tambi BrianDirectorMay 19Sale60.011,20072,0120May 20 05:28 PM
BAKER DARRYL SChief Financial OfficerMay 18Sale59.1710,000591,7209,377May 18 04:02 PM
MEYER STEVEN JDirectorMay 11Option Exercise3.2518,00058,50023,000May 11 07:33 PM
MEYER STEVEN JDirectorMay 11Sale57.0618,0001,027,1605,000May 11 07:33 PM
Babich Michael LPresident and CEOMar 20Option Exercise3.255,00016,250207,752Mar 20 04:43 PM
Babich Michael LPresident and CEOMar 17Option Exercise7.2627,400198,924230,152Mar 18 04:49 PM
Babich Michael LPresident and CEOMar 17Sale57.7527,4001,582,441202,752Mar 18 04:49 PM
Babich Michael LPresident and CEOMar 16Option Exercise2.8277,600218,877250,352Mar 18 04:49 PM
Babich Michael LPresident and CEOMar 16Sale59.1347,6002,814,473202,752Mar 18 04:49 PM
FOURTEAU PATRICKDirectorMar 11Sale59.9410,000599,35970,000Mar 12 10:36 AM
STANLEY THEODORE HDirectorMar 10Option Exercise7.263,30023,9584,300Mar 10 04:47 PM
STANLEY THEODORE HDirectorMar 10Sale60.033,300198,0861,000Mar 10 04:47 PM
STANLEY THEODORE HDirectorMar 05Option Exercise7.266,70048,6427,700Mar 06 08:03 PM
STANLEY THEODORE HDirectorMar 05Sale60.116,700402,7461,000Mar 06 08:03 PM